Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
900 participants
INTERVENTIONAL
2013-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. The development of an Internet-based Virtual Reality intervention for preventing PTSD among patients who have recently experienced a traumatic event.
2. The evaluation of the feasibility of administering this intervention, and
3. The evaluation of the efficacy of this Internet based intervention in the prevention of PTSD in recent trauma survivors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Post Traumatic Stress Disorder by Early Treatment
NCT00146900
Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse
NCT00656344
Examining an Emergency Room Intervention for the Prevention of Post Traumatic Stress Disorder (PTSD)
NCT01162044
Prevention of PTSD III: Neurocognitive Training of Emotional Regulation
NCT02085512
Virtual Reality and Post Traumatic Stress
NCT06684977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
intervention delivered via internet
CBT delivered via Internet
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CBT delivered via Internet
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjectively involves helplessness or fear);
* Aged over 18; Aged under 65;
* Hebrew speaking; Suffering from PTSD (without the time criteria i.e. less than one month of symptoms);
* Able to give informed consent.
Exclusion Criteria
* Suffering from, or have suffered from in the past, psychotic disorder;
* Suffering from, or have suffered from in the past, substance abuse;
* Suffering from PTSD;
* Suffering from another Axis I anxiety disorder that requires immediate treatment;
* Currently presents as a suicide risk, requiring hospitalization.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bar-Ilan University, Israel
OTHER
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rena Cooper, MD
Role: PRINCIPAL_INVESTIGATOR
HMO
Sara Freedman, PhD
Role: STUDY_DIRECTOR
Bar Ilan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah medical organization
Jerusalem, Israel, Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VRInternet
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.